AGTR1 and Alzheimer disease: The magnitude of anti-inflammatory and anti-oxidative benefits associated with ARBs through inverse agonism at the AT1R [66, 67] and upregulation of AT2R and AT4R activity [68, 69] might be amplified in AD.